Annual Conference

Now Open! Call for Abstracts for the General Poster Session

NCCN welcomes original abstracts from investigators in the general oncology community. Submissions will be accepted from academic institutions, teaching and community hospitals, or industry. Participants from both NCCN and non-NCCN Member Institutions may submit abstracts.

The NCCN General Poster Session, including submission review, is overseen by the NCCN Oncology Research Program (ORP). The submission deadline is Wednesday, November 10, 2021, 11:59 pm ET. Corresponding authors can expect to receive notification via e-mail in mid-December 2021.

SUBMIT ABSTRACT

Save the Dates!

NCCN 2022 Annual Conference
Thursday, March 31, 2022 – Saturday, April 2, 2022

NCCN 2022 Nursing Program: Advancing Oncology Nursing™
Wednesday, March 30, 2022

NCCN 2022 Oncology Fellows Program: New Horizons in Quality Cancer Care
Sunday, April 3, 2022

NCCN 2022 Annual Conference Update

NCCN remains committed to lessening the transmission risk of COVID-19 and continues to monitor and follow the guidelines and recommendations provided by the Centers for Disease Control and Prevention, as well as local and state health agencies, related to conducting live meetings and events. Information provided by these agencies could result in modifications, restrictions, or even the cancellation of live events or certain functions.

At this time, NCCN is planning for the Conference and related activities to be held as “hybrid” events on March 30 – April 3, 2022 to include live (in-person) and a virtual option. The live sessions will be held at the Rosen Shingle Creek, Orlando, FL and simultaneously, we will provide a virtual platform where certain activities/sessions will be offered for remote attendance.

Should plans change, we will make every effort to communicate updated information as quickly and efficiently as possible. Please check back for additional updates.

View topics below or visit education.nccn.org/ac2021 for more information.

Keynote Sessions

Best Practices in Oncology

Breast Cancer

Cutaneous Melanoma

Gastrointestinal Cancers

Genitourinary Cancers

Gynecological Malignancies

Head and Neck Cancers

Hematologic Malignancies

Non-Small Cell Lung Cancer

Supportive Care/Survivorship

Other Topics

Additional activities

View recorded presentations from the NCCN 2021 Virtual Nursing Program: Advancing Oncology Nursing™

View recorded presentations from the NCCN 2021 Virtual Oncology Fellows Program: New Horizons in Quality Cancer Care

This activity is supported by educational grants from:

Abbott's molecular business
Adaptive Biotechnologies
AstraZeneca
BeiGene, Ltd.
Blueprint Medicines
Daiichi Sankyo
Deciphera Pharmaceuticals
Eisai
Exact Sciences
Genentech, a member of the Roche Group
Gilead Sciences
GlaxoSmithKline
GRAIL, Inc.
Ipsen Biopharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc.
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Lilly
Olympus Corporation of the Americas
Novartis
Pfizer
Puma Biotechnology
Seagen Inc. formerly Seattle Genetics
Taiho Oncology, Inc.
TeSera Therapeutics

This activity is supported by independent medical education grants from:

Bristol Myers Squibb
Illumina, Inc.
Regeneron Pharmaceuticals, Inc and Sanofi Genzyme

This activity is supported by independent educational grants from:

AbbVie
Astellas
Boehringer Ingelheim Pharmaceuticals, Inc.
Incyte
Merck & Co., Inc.

This activity is supported by educational funding provided by Amgen.

This educational activity is supported by a medical education grant from Exelixis, Inc. & Karyopharm® Therapeutics.

This project has been made possible in part by a grant from Varian Medical Systems/Global Medical Education Grant Program.

View abstracts from the NCCN 2021 Virtual Annual Conference in JNCCN-Journal of the National Comprehensive Cancer Network.

More than 90 posters were accepted to participate in the NCCN Virtual Poster Exhibition Hall throughout the following categories.